Skip to main content
Clinical Trials/NCT06153992
NCT06153992
Recruiting
Not Applicable

Clinical Application of Portable Intelligent Multi Joint Isokinetic Training and Evaluation System Technology

Ran Shi1 site in 1 country90 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Ran Shi
Enrollment
90
Locations
1
Primary Endpoint
Body function
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to compare in describeparticipant population. The main question it aims to answer is:By using intelligent portable isokinetic tester and traditional isokinetic tester, isokinetic knee flexor and extensor muscles of stroke patients with hemiplegia were trained respectively, so as to observe and compare the effects of the two treatment methods. In addition, the therapeutic effect of the above two treatments was compared with that of exercise therapy alone. Participants will be divided into three groups: control group, intelligent isokinetic treatment group, and traditional isokinetic treatment group. Participants of both the control group and the two treatment groups received exercise therapy. On the basis of exercise therapy, participants of the intelligent isokinetic treatment group used the intelligent portable isokinetic tester to train the affected knee flexion and extensor muscle, while the participants of traditional isokinetic treatment group used the intelligent portable isokinetic tester to train the affected knee flexion and extensor muscle.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
December 20, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ran Shi
Responsible Party
Sponsor Investigator
Principal Investigator

Ran Shi

doctor

Qianfoshan Hospital

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Cerebral apoplexy's Disease
  • Confirmed by CT or MR Examination of the head
  • First onset, duration ≤1 month
  • The lower extremity of the hemiplegic limb was above Brunnstrom stage III
  • Must be able to sign the informed consent form

Exclusion Criteria

  • Vital signs are unstable
  • Severe cognitive, visual and hearing impairment
  • Orthopaedic disease
  • Muscle pain lower extremity
  • Congenital disease
  • History of other encephalopathy
  • History of mental illness

Outcomes

Primary Outcomes

Body function

Time Frame: up to 1 month

Evaluate lower limb motor function using the Fugl Meyer method (total lower limb motor score 0-34 points, total balance score 0-14 points).

Measured peak moment

Time Frame: up to 1 month

Peak moment of knee joint at 60 °/s angular velocity in Nm

Secondary Outcomes

  • Satisfaction questionnaire survey(up to 1 month)

Study Sites (1)

Loading locations...

Similar Trials